Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market Analysis-2027

1. DIABETES DEVICES AND DRUGS (DIAGNOSIS, MONITORING, AND THERAPEUTICS) MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market - Overview Diabetes may give rise to other conditions related to the eyes, nervous system, heart, kidney, and skin. There are several types of insulin used in the treatment of diabetes that include, rapid-acting, short-acting, intermediate-acting, long-acting, and pre-mixed. Continuous glucose monitoring is a FDA-approved approach that measures blood sugar level in the management of diabetes. The global Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market is estimated to account for US$ 118,955.0 Mn in terms of value in 2020 and is expected to reach US$ 231,909.8 Mn by the end of 2027. Global Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market: Drivers R&D of novel therapies for the treatment of diabetes is expected to boost growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market over the forecast period. For instance, in April 2020, Hua Medicine, a clinical-stage drug development company based in China, announced positive results of a clinical study that assessed the efficacy of metformin, DPP-4 inhibitors or SGLT-2 inhibitors, alone or in combination treatment, in the treatment of type 2 diabetes. For instance, in April 2020, JDRF, a nonprofit 501 organization based in the U.S., announced to raise US$ 2.5 million for R&D in type 1 diabetes through JDRF House ParT1D for a Cure. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/diabetes-devices-and-drugs-market-3857 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market: Restraints Adverse effects of drugs used in the treatment of diabetes are expected to limit growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. For instance, sulfonylureas, a class of drugs widely used in the management of diabetes mellitus type 2, may led to low blood sugar, upset stomach, skin rash or itching, weight gain. Key Takeaways: The global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market was valued at US$ 108,190.4 Mn in 2019 and is forecast to reach a value of US$ 231,909.8 Mn by 2027 at a CAGR of 10.0% between 2020 and 2027. Factors such as increasing research and development of diabetes treatments, and diagnostic products is supporting growth of the market. Therapeutics held dominant position in the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market in 2019, accounting for 74.1% share in terms of value, followed by diagnosis & monitoring. Therapeutics segment consists of treatment options such as insulin which is a blockbuster treatment. Moreover presence of other drugs is also expected to support growth of the market over the forecast period. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3857 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends Increasing geriatric population in Asia Pacific is expected to boost growth of the market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. For instance, AstraZeneca’s Bydureon (exenatide) used for the treatment of type 2 diabetes is expected to face patent expiration in October 2020. Global Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market: Competitive Landscape Major players operating in the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market include, Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi. Global Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market: Key Developments April 2020: DexCom, Inc. launched a new patient assistance program that offers two 90-day supply shipments of Dexcom continuous glucose monitoring (CGM) system supplies and reduces customer cost to US$ 45 per 90-day supply shipment, in order to aid current U.S. customers who have lost insurance due to the COVID-19 pandemic Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3857 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved